Benitec Biopharma Inc. Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit
Benitec Biopharma Inc. (BNTC) had Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit of $0 as of 2022-06-30, per its 10-K filed 2022-09-02.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit · last filed 2022-09-02
- 2022-06-30: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
- 2021-06-30: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
- 2020-06-30: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
| Period end | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit |
|---|---|
| 2022-06-30 | $0.00 10-K · filed 2022-09-02 |
| 2021-06-30 | $0.00 10-K · filed 2021-09-20 |
| 2020-06-30 | $0.00 10-K · filed 2020-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |